Timing vaccination against SARS-CoV-2

Cell Res. 2021 Nov;31(11):1146-1147. doi: 10.1038/s41422-021-00559-w.

Authors

Coline Barnoud¹, Chen Wang¹, Christoph Scheiermann^{2

3}

Affiliations

¹ Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
² Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. christoph.scheiermann@unige.ch.
³ Walter-Brendel-Centre of Experimental Medicine, BioMedical Centre, Ludwig-Maximilians-University München, Planegg-Martinsried, München, Germany. christoph.scheiermann@unige.ch.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Humans
SARS-CoV-2*
Vaccination

Grants and funding